Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Bright Minds Biosciences Inc. (DRUG) Institutional Ownership & Insider Trading

100 institutions reported holding Bright Minds Biosciences Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · read by EquiReason

DRUGBright Minds Biosciences Inc.Follow DRUG — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
237.4M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Aug, in -68 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

100 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +0.8%.

Increased+46New+18Decreased-17Closed-9

Largest moves, shares (millions)

Point72 Asset Management+0.3MParkman Healthcare Partners+0.2MCitadel Advisors+0.1MPerceptive Advisors-0.4MAdage Capital Partners Gp-0.2MCormorant Asset Management-0.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-0.0Sep 24+0.0Dec 24+0.3Mar 25+0.0Jun 25+0.8Sep 25+0.6Dec 25+2.3Mar 26+0.1Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 261009+0.8%4618179
Mar 26939+35.1%4324157
Dec 25747+9.1%2517186
Sep 25636+15.5%1917120
Jun 25475+0.3%52399
Mar 25335+6.5%10975
Dec 24305—————
Sep 2460—1101

Bright Minds Biosciences Inc. — questions

Who owns Bright Minds Biosciences Inc. stock?
100 institutions reported Bright Minds Biosciences Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Jupiter Topco LLC (29.8%), Cormorant Asset Management, LP (19.9%), BlackRock, Inc. (15.2%).

Every figure on this page comes from Bright Minds Biosciences Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.